Logo image of EXEL

EXELIXIS INC (EXEL) Stock Analyst Ratings

NASDAQ:EXEL - Nasdaq - US30161Q1040 - Common Stock - Currency: USD

36.85  +1.76 (+5.02%)

After market: 36.84 -0.01 (-0.03%)

Buy % Consensus

76

ChartMill assigns a Buy % Consensus number of 76% to EXEL. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 37.74. This target is 2.42% above the current price.
EXEL was analyzed by 29 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about EXEL.
In the previous month the buy percentage consensus was at a similar level.
EXEL was analyzed by 29 analysts, which is quite many. So the average rating should be quite meaningful.
EXEL Historical Analyst RatingsEXEL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -98 -89 -80 -71 -62 -53 -44 -35 -26 -17 -8 5 10 15 20 25

Price Target & Forecast

Price Low Median Mean High 36.8523.2338.7637.7447.25 - -36.96% 5.18% 2.42% 28.22%
EXEL Current Analyst RatingEXEL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2025-02-13 Barclays Maintains Equal-Weight -> Equal-Weight
2025-02-13 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-12 Guggenheim Reiterate Buy -> Buy
2025-02-12 Stephens & Co. Reiterate Equal-Weight -> Equal-Weight
2025-02-12 Stifel Maintains Hold -> Hold
2025-02-12 Piper Sandler Maintains Overweight -> Overweight
2025-02-12 Citigroup Maintains Buy -> Buy
2025-01-28 UBS Maintains Neutral -> Neutral
2025-01-27 JMP Securities Maintains Market Outperform -> Market Outperform
2025-01-27 Stephens & Co. Reiterate Equal-Weight -> Equal-Weight
2025-01-27 Truist Securities Maintains Buy -> Buy
2025-01-27 Morgan Stanley Upgrade Equal-Weight -> Overweight
2025-01-27 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-24 Oppenheimer Downgrade Outperform -> Perform
2025-01-23 JMP Securities Reiterate Market Outperform -> Market Outperform
2025-01-22 Guggenheim Reiterate Buy -> Buy
2025-01-16 Oppenheimer Maintains Outperform -> Outperform
2025-01-15 JMP Securities Maintains Market Outperform -> Market Outperform
2025-01-15 Truist Securities Maintains Buy -> Buy
2025-01-13 Piper Sandler Maintains Overweight -> Overweight
2025-01-10 HC Wainwright & Co. Maintains Buy -> Buy
2025-01-07 Guggenheim Maintains Buy -> Buy
2024-12-23 Brookline Capital Initiate Buy
2024-12-20 BMO Capital Downgrade Outperform -> Market Perform
2024-12-17 B of A Securities Downgrade Buy -> Neutral
2024-10-30 Guggenheim Maintains Buy -> Buy
2024-10-30 BMO Capital Maintains Outperform -> Outperform
2024-10-30 RBC Capital Reiterate Outperform -> Outperform
2024-10-30 Stephens & Co. Maintains Equal-Weight -> Equal-Weight
2024-10-30 Wells Fargo Maintains Overweight -> Overweight